A refractory case of CDK4 -amplified spinal astrocytoma achieving complete response upon treatment with a Palbociclib-based regimen:a case report | BMC Cancer | Full Text

A refractory case of CDK4 -amplified spinal astrocytoma achieving complete response upon treatment with a Palbociclib-based regimen:a case report | BMC Cancer | Full Text

A refractory case of CDK4-amplified spinal astrocytoma achieving complete response upon treatment with a Palbociclib-based regimen:a case report

Spinal cord astrocytoma is a rare neoplasm, and patients usually recur within months after surgery. There is currently a lack of consensus regarding post-operative treatment. Clinical data on the activity of s...

Authors:Jietao Lin, Ling Yu, Yuanfeng Fu, Hanrui Chen, Xinting Zheng, Shutang Wang, Chan Gao, Yang Cao and Lizhu Lin

Citation:BMC Cancer 2020 20:630

Content type:Case report

 

Published on: 8 July 2020

• ViewFull Text
 
• ViewPDF